Published in The New England Journal of Medicine and presented at the ADAs 85th Scientific Sessions, the findings show that CagriSema, an innovative combination of semaglutide (a GLP-1 receptor agonist) and cagrilintide (an amylin analogue) achieved significant and clinically meaningful weight loss when paired with lifestyle interventions over a 68-week period
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test reveals predispositions in GLP-1 receptor (GLP1R rs6923761), GIPR (rs1800437), and metabolic pathways (FTO rs9939609, MC4R rs17782313) that may help provide context for how your body responds to GLP-1 signaling
This hormone is vital in managing appetite, digestion, and blood sugar
Reduced glutathione is a tripeptide composed of three amino acids (cysteine, glycine, and glutamic acid) and serves as a powerful antioxidant in the body
The typical tirzepatide titration schedule takes 1220 weeks to reach maintenance doses of 1015 mg, depending on your tolerance
Additional TRANSCEND-T2D trials: Long-term diabetes outcomes
